Short-range intercellular calcium signaling in bone

APMIS, Supplement

Volumn 113, Issue 118, 2005, Pages 1-36

  Jørgensen, Niklas Rye ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CYCLIC AMP; GAP JUNCTION PROTEIN; INSULIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PURINE P2 RECEPTOR;

BONE EROSION; BONE GROWTH; BONE MASS; BONE MATURATION; BONE MINERALIZATION; BONE REMODELING; BONE TURNOVER; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL COMMUNICATION; CELL FATE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; COCULTURE; CYTOLYSIS; EXPLANT; GAP JUNCTION; GOLGI COMPLEX; INSULIN RELEASE; MECHANICAL STIMULATION; MECHANOTRANSDUCTION; MULTIPOTENT STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOSARCOMA; OSTEOSARCOMA CELL; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SECOND MESSENGER; ANIMAL; BONE; CELL JUNCTION; CYTOLOGY; DRUG EFFECT; HUMAN; INTRACELLULAR FLUID; KINETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE AND BONES; CALCIUM; CALCIUM SIGNALING; CELL COMMUNICATION; GAP JUNCTIONS; HUMANS; INTRACELLULAR FLUID; KINETICS; OSTEOBLASTS; OSTEOCLASTS;

EID: 27744608522     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (191)

1. Primer on the metabolic bone diseases and disorders of mineral metabolism. New York, Lippincott-Raven, 1996.
2. Aubin JE, Liu F, Malaval L, Gupta AK. Osteoblast and chondroblast differentiation. Bone 1995;17:S77S-S83.
3. Rodan GA. Introduction to bone biology. Bone 1992;13(Suppl 1):S3-S6.
4. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 1990;319:311-9.
5. Weryha G, Leclere J. Paracrine regulation of bone remodeling. Horm Res 1995;75:69-75.
6. Tatakis DN. Interleukin-1 and bone metabolism: a review. J Periodontol 1993;431:416-31.
7. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996;1051:1043-51.
8. Mundy GR, Boyce B, Hughes D, et al. The effects of cytokines and growth factors on osteoblastic cells. Bone 1995;17:S71-S75.
9. Majeska R. Culture of osteoblastic cells. Principles of Bone Biology. Academic Press, Inc., 1996: pp. 1229-37.
10. Majeska RJ, Rodan SB, Rodan GA. Maintenance of parathyroid hormone response in clonal rat osteosarcoma lines. Exp Cell Res 1978;468:465-8.
11. Partridge NC, Alcorn D, Michelangeli VP, Ryan G, Martin TJ. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res 1983;4314:4308-14.
12. Jorgensen NR, Geist ST, Civitelli R, Steinberg TH. ATP- and gap junction-dependent intercellular calcium signaling in osteoblastic cells. J Cell Biol 1997;506:497-506.
13. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 1992;92X:683-92X.
14. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983;198:191-8.
15. Kassem M. Cellular and molecular effects of growth hormone and estrogen on human bone cells. APMIS Suppl 1997;30:1-30.
16. Kassem M, Risteli L, Mosekilde L, Melsen F, Eriksen EF. Formation of osteoblast-like cells from human mononuclear bone marrow cultures. APMIS 1991;274:269-74.
17. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 1996;324:312-324.
18. Jorgensen NR, Henriksen Z, Brot C, et al. Human osteoblastic cells propagate intercellular calcium signals by two different mechanisms. J Bone Miner Res 2000;1032:1024-32.
19. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 1994;286:277-86.
20. Wong MM, Rao LG, Ly H, et al. Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells. J Bone Miner Res 1990;813:803-13.
21. Jorgensen NR, Henriksen Z, Sorensen OH, Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype in human bone marrow derived stromal cells. In press, Steroids.
22. Lecanda F, Avioli LV, Cheng SL. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 1997;396:386-96.
23. Fromigué O, Marie PJ, Lomri A. Bone morphogenetic prtoein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 1998;426:411-26.
24. Quinn JM, Neale S, Fujikawa Y, McGee JO, Athanasou NA. Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif Tissue Int 1998;531:527-31.
25. Aslanidi OV, Mornev OA, Skyggebjerg O, et al. Excitation wave propagation as a possible mechanism for signal transmission in pancreatic islets of langerhans. Biophys J 2001;1209:1195-209.
26. Vaananen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J Cell Sci 2000;113(Pt 3):377-81.
27. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;1508:1504-8.
28. Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 1993;1744:1733-44.
29. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N. Modulation of osteoclast differentiation by local factors. Bone 1995;17:S87-S91.
30. Blair HC. How the osteoclast degrades bone. Bioessays 1998;846:837-46.
31. Kassem M, Mosekilde L, Rungby J, Melsen F, Eriksen EF. Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures. APMIS 1991;268:262-8.
32. Matsuzaki K, Udagawa N, Takahashi N, et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 1998;204:199-204.
33. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;3602:3597-602.
34. Quinn JM, Elliott J, Gillespie MT, Martin TJ. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 1998;4427:4424-7.
35. Jorgensen NR, Henriksen Z, Sorensen OH, Eriksen EF, Civitelli R, Steinberg TH. Intercellular Calcium Signaling Occurs between Human Osteoblasts and Osteoclasts and Requires Activation of Osteoclast P2X7 Receptors. J Biol Chem 2002;7580:7574-80.
36. Osipchuk Y, Cahalan M. Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 1992;244:241-4.
37. Schlosser SF, Burgstahler AD, Nathanson MH. Isolated rat hepatocytes can signal to other hepatocytes and bile duct cells by release of nucleotides. Proc Natl Acad Sci USA 1996;9953:9948-53.
38. Brake AJ, Julius D. Signaling by extracellular nucleotides. Annu Rev Cell Dev Biol 1996;541:519-41.
39. Hofer AM, Curci S, Doble MA, Brown EM, Soybel DI. Intercellular communication mediated by the extracellular calcium-sensing receptor [see comments]. Nat Cell Biol 2000;398:392-8.
40. Boitano S, Dirksen ER, Sanderson MJ. Intercellular propagation of calcium waves mediated by inositol trisphosphate. Science 1992;295:292-5.
41. 2+- conducting ion channels in mechanically-induced signal transduction of airway epithelial cells. J Cell Sci 1994;3044:3037-44.
42. Sanderson MJ, Charles AC, Dirksen ER. Mechanical stimulation and intercellular communication increases intracellular Ca2+ in epithelial cells. Cell Regul 1990;596:585-96.
43. Deitmer JW, Verkhratsky AJ, Lohr C. Calcium signalling in glial cells. Cell Calcium 24:405-16.
44. Sanderson MJ, Chow I, Dirksen ER. Intercellular communication between ciliated cells in culture. Am J Physiol 1988;254:C63-C74.
45. Hansen M, Boitano S, Dirksen ER, Sanderson MJ. Intercellular calcium signaling induced by extracellular adenosine 5′-triphosphate and mechanical stimulation in airway epithelial cells. J Cell Sci 1993;1004:995-1004.
46. Evans JH, Sanderson MJ. Intracellular calcium oscillations induced by ATP in airway epithelial cells. Am J Physiol 1999;277:L30-L41.
47. Homolya L, Steinberg TH, Boucher RC. Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J Cell Biol 2000;1360:1349-60.
48. D'Andrea P, Calabrese A, Capozzi I, Grandolfo M, Tonon R, Vittur F. Intercellular Ca2+ waves in mechanically stimulated articular chondrocytes. Biorheology 2000;83:75-83.
49. D'Andrea P, Vittur F. Gap junctions mediate intercellular calcium signalling in cultured articular chondrocytes. Cell Calcium 1996;397:389-97.
50. D'Andrea P, Vittur F. Spatial and temporal Ca2+ signalling in articular chondrocytes. Biochem Biophys Res Commun 1995;135:129-35.
51. Guilak F, Zell RA, Erickson GR, et al. Mechanically induced calcium waves in articular chondrocytes are inhibited by gadolinium and amiloride. J Orthop Res 1999;429:421-9.
52. D'Andrea P, Vittur F. Propagation of intercellular Ca2+ waves in mechanically stimulated articular chondrocytes. FEBS Lett 1997;64:58-64.
53. Charles AC, Naus CC, Zhu D, Kidder GM, Dirksen ER, Sanderson MJ. Intercellular calcium signaling via gap junctions in glioma cells. J Cell Biol 1992;201:195-201.
54. Charles AC, Merrill JE, Dirksen ER, Sanderson MJ. Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. Neuron 1991;992:983-92.
55. Naus CC, Bechberger JF, Zhang Y, et al. Altered gap junctional communication, intercellular signaling, and growth in cultured astrocytes deficient in connexin43. J Neurosci Res 1997;540:528-40.
56. Venance L, Piomelli D, Glowinski J, Giaume C. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature 1995;594:590-4.
57. Venance L, Stella N, Glowinski J, Giaume C. Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. J Neurosci 1997;1992:1981-92.
58. Yao J, Morioka T, Li B, Oite T. Coordination of mesangial cell contraction by gap junction-mediated intercellular Ca(2+) wave. J Am Soc Nephrol 2002;2026:2018-26.
59. Young SH, Ennes HS, Mayer EA. Propagation of calcium waves between colonic smooth muscle cells in culture. Cell Calcium 1996;271:257-71.
60. Christ GJ, Moreno AP, Melman A, Spray DC. Gap junction-mediated intercellular diffusion of Ca2+ in cultured human corporal smooth muscle cells. Am J Physiol 1992;263:C373-C383.
61. Saez JC, Connor JA, Spray DC, Bennett MV Hepatocyte gap junctions are permeable to the second messenger, inositol 1,4,5-triphosphate, and to calcium ions. Proc Natl Acad Sci USA 1989;2712:2708-12.
62. Grierson JP, Meldolesi J. Shear stress-induced [Ca2+]i transients and oscillations in mouse fibroblasts are mediated by endogenously released ATP. J Biol Chem 1995;4456:4451-6.
63. Churchill GC, Atkinson MM, Louis CF. Mechanical stimulation initiates cell-to-cell calcium signaling in ovine lens epithelial cells. J Cell Sci 1996;65X:355-65X.
64. Suadicani SO, Vink MJ, Spray DC. Slow intercellular Ca(2+) signaling in wild-type and Cx43-null neonatal mouse cardiac myocytes. Am J Physiol Heart Circ Physiol 2000;279: H3076-H3088.
65. Sanderson MJ, Dirksen ER. Mechanosensitivity of cultured ciliated cells from the mammalian respiratory tract: implications for the regulation of mucociliary transport. Proc Natl Acad Sci USA 1986;736X:7302-736X.
66. Sakuma N, Ishikawa S, Okada K, Miyazaki J, Saito T. Glucose induces calcium-dependent and calcium-independent insulin secretion from the pancreatic beta cell line MIN6. Eur J Endocrinol 1995;34X:227-34X.
67. Cao D, Lin G, Westphale EM, Beyer EC, Steinberg TH. Mechanisms for the coordination of intercellular calcium signaling in insulin-secreting cells. J Cell Sci 1997;504:497-504.
68. Bertuzzi F, Davalli AM, Nano R, et al. Mechanisms of coordination of Ca2+ signals in pancreatic islet cells. Diabetes 1999;1978:1971-8.
69. Schwiebert EM. Extracellular ATP-mediated propagation of Ca(2+) waves. Focus on "mechanical strain-induced Ca(2+) waves are propagated via ATP release and purinergic receptor activation". Am J Physiol Cell Physiol 2000;279:C281-C283.
70. Berridge MJ. The biology and medicine of calcium signalling. Mol Cell Endocrinol 1994;124:119-24.
71. Sanderson MJ, Charles AC, Boitano S, Dirksen ER. Mechanisms and function of intercellular calcium signaling. Mol Cell Endocrinol 1994;187:173-87.
72. Rottingen J, Iversen JG. Ruled by waves? Intracellular and intercellular calcium signalling. Acta Physiol Scand 2000;219:203-19.
73. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nature Reviews 2000;21:11-21.
74. Xia SL, Ferrier J. Propagation of a calcium pulse between osteoblastic cells. Biochem Biophys Res Commun 1992;1219:1212-9.
75. Jorgensen NR, Teilmann SC, Henriksen Z, Civitelli R, Sorensen OH, Steinberg TH. Activation of L-type calcium channels is required for gap junction-mediated intercellular calcium signaling in osteoblastic cells. J Biol Chem 2003;4086:4082-6.
76. Jorgensen NR, Henriksen Z, Sorensen OH, Civitelli R, Steinberg TH. In vitro differentiation of human osteoblast-like cells alters the predominant mechanism of intercellular calcium wave propagation. J Bone Miner Res 1999.
77. Saez JC, Berthoud VM, Moreno AP, Spray DC. Gap junctions. Multiplicity of controls in differentiated and undifferentiated cells and possible functional implications. Adv Second Messenger Phosphoprotein Res 1993;198:163-98.
78. Beyer EC, Paul DL, Goodenough DA. Connexin family of gap junction proteins. J Membr Biol 1990;194:187-94.
79. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996;38X:381-38X.
80. Willecke K, Eiberger J, Degen J, et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002;737:725-37.
81. Steinberg TH. Gap junction function: the messenger and the message [comment]. Am J Pathol 1998;854:851-4.
82. Musil LS, Goodenough DA. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol 1991;1374:1357-74.
83. Laird DW, Castillo M, Kasprzak L. Gap junction turnover, intracellular trafficking, and phosphorylation of connexin43 in brefeldin A-treated rat mammary tumor cells. J Cell Biol 1995;1203:1193-203.
84. Romanello M, D'Andrea P. Dual mechanism of intercellular communication in HOBIT osteoblastic cells: a role for gap-junctional hemichannels. J Bone Miner Res 2001;1476:1465-76.
85. Cotrina ML, Lin JH, Alves-Rodrigues A, et al. Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA 1998;15740:15735-40.
86. Arcuino G, Lin JH, Takano T, et al. Intercellular calcium signaling mediated by point-source burst release of ATP. Proc Natl Acad Sci USA 2002;9845:9840-5.
87. Romanello M, Pani B, Bicego M, D'Andrea P. Mechanically induced ATP release from human osteoblastic cells. Biochem Biophys Res Commun 2001;1281:1275-81.
88. Goldberg GS, Bechberger JF, Naus CC. A preloading method of evaluating gap junctional communication by fluorescent dye transfer. Biotechniques 1995;497:490-7.
89. Ziambaras K, Lecanda F, Steinberg TH, Civitelli R. Cyclic stretch enhances gap junctional communication between osteoblastic cells. J Bone Miner Res 1998;228:218-28.
90. Doty SB, Schofield BH. Metabolic and structural changes within osteocytes of rat bone. In: Talmage RV, Munson PL (Eds.). Calcium, parathyroid hormone and the calcitonins. Amsterdam, Netherlands, Excerptas Media, 1972: pp. 353-64.
91. Doty SB. Morphological evidence of gap junctions between bone cells. Calcif Tissue Int 1981;511:509-11.
92. Palumbo C, Palazzini S, Marotti G. Morphological study of intercellular junctions during osteocyte differentiation. Bone 1990;406:401-6.
93. Jones SJ, Gray C, Sakamaki H, et al. The incidence and size of gap junctions between the bone cells in rat calvaria. Anat Embryol (Berl) 1993;352:343-52.
94. Shapiro F. Variable conformation of GAP junctions linking bone cells: a transmission electron microscopic study of linear, stacked linear, curvilinear, oval, and annular junctions. Calcif Tissue Int 1997;293:285-93.
95. Civitelli R, Beyer EC, Warlow PM, Robertson AJ, Geist ST, Steinberg TH. Connexin43 mediates direct intercellular communication in human osteoblastic cell networks. J Clin Invest 1993;1896:1888-96.
96. Schiller PC, Mehta PP, Roos BA, Howard GA. Hormonal regulation of intercellular communication: parathyroid hormone increases connexin 43 gene expression and gap-junctional communication in osteoblastic cells. Mol Endocrinol 1992;1440:1433-40.
97. Donahue HJ, McLeod KJ, Rubin CT, et al. Cell-to-cell communication in osteoblastic networks: cell line-dependent hormonal regulation of gap junction function. J Bone Miner Res 1995;889:881-9.
98. Donahue HJ, Li Z, Zhou Z, Yellowley CE. Differentiation of human fetal osteoblastic cells and gap junctional intercellular communication. Am J Physiol Cell Physiol 2000;278: C315-C322.
99. Steinberg TH, Civitelli R, Geist ST, et al. Connexin43 and connexin45 form gap junctions with different molecular permeabilities in osteoblastic cells. EMBO J 1994;750:744-50.
100. Koval M, Geist ST, Westphale EM, et al. Transfected connexin45 alters gap junction permeability in cells expressing endogenous connexin43. J Cell Biol 1995;995:987-95.
101. Civitelli R, Ziambaras K, Warlow PM, et al. Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells. J Cell Biochem 1998;21:8-21.
102. Massas R, Benayahu D. Parathyroid hormone effect on cell-to-cell communication in stromal and osteoblastic cells. J Cell Biochem 1998;86:81-6.
103. Mitchell JA, Ou C, Chen Z, Nishimura T, Lye SJ. Parathyroid hormone-induced up-regulation of connexin-43 messenger ribonucleic acid (mRNA) is mediated by sequences within both the promoter and the 3′ untranslated region of the mRNA. Endocrinology 2001;915:907-15.
104. Schiller PC, D'Ippolito G, Balkan W, Roos BA, Howard GA. Gap-junctional communication mediates parathyroid hormone stimulation of mineralization in osteoblastic cultures. Bone 2001;44:38-44.
105. Chiba H, Sawada N, Oyamada M, et al. Hormonal regulation of connexin 43 expression and gap junctional communication in human osteoblastic cells. Cell Struct Funct 1994;177:173-7.
106. Wyatt LE, Chung CY, Carlsen B, et al. Bone morphogenetic protein-2 (BMP-2) and transforming growth factor-beta1 (TGF-beta1) alter connexin 43 phosphorylation in MC3T3-E1 Cells. BMC Cell Biol 2001;2:14.
107. Zhang W, Green C, Stott NS. Bone morphogenetic protein-2 modulation of chondrogenic differentiation in vitro involves gap junction-mediated intercellular communication. J Cell Physiol 2002;243:233-43.
108. Schirrmacher K, Bingmann D. Effects of vitamin D3, 17beta-estradiol, vasoactive intestinal peptide, and glutamate on electric coupling between rat osteoblast-like cells in vitro. Bone 1998;526:521-6.
109. Massas R, Korenstein R, Benayahu D. Estrogen modulation of osteoblastic cell-to-cell communication. J Cell Biochem 1998;290:282-90.
110. Doualla-Bell F, Lye SJ, Labrie F, Fortier MA. Differential expression and regulation of connexin-43 and cell-cell coupling in myocytes from the circular and longitudinal layers of bovine myometrium. Endocrinology 1995;5328:5322-8.
111. Risek B, Klier FG, Phillips A, Hahn DW, Gilula 33 NB. Gap junction regulation in the uterus and ovaries of immature rats by estrogen and progesterone. J Cell Sci 1995;108(Pt 3):1017-32.
112. Burghardt RC, Anderson E. Hormonal modulation of gap junctions in rat ovarian follicles. Cell Tissue Res 1981;193:181-93.
113. Doty SB, Morey-Holton ER. Changes in osteoblastic activity due to simulated weightless conditions. Physiologist 1982;25:S141-S142.
114. Luo LC, Yu H, Ferrier J. Differential purinergic receptor signalling in osteoclasts and osteoblastic cells. Cell Signal 1997;607:603-7.
115. Cheng B, Zhao S, Luo J, Sprague E, Bonewald LF, Jiang JX. Expression of functional gap junctions and regulation by fluid flow in osteocyte-like MLO-Y4 cells. J Bone Miner Res 2001;259:249-59.
116. Donahue HJ. Gap junctional intercellular communication in bone: a cellular basis for the mechanostat set point [editorial]. Calcif Tissue Int 1998;88:85-8.
117. Burger EH, Klein N. Mechanotransduction in bone-role of the lacuno-canalicular network. FASEB J 1999;13(Suppl):S101-S112.
118. Donahue HJ. Gap junctions and biophysical regulation of bone cell differentiation. Bone, 2000;422:417-22.
119. Yellowley CE, Li Z, Zhou Z, Jacobs CR, Donahue HJ. Functional gap junctions between osteocytic and osteoblastic cells. J Bone Miner Res 2000;217:209-17.
120. Su M, Borke JL, Donahue HJ, et al. Expression of connexin 43 in rat mandibular bone and periodontal ligament (PDL) cells during experimental tooth movement. J Dent Res 1997;1366:1357-66.
121. Beyer EC, Steinberg TH. Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages. J Biol Chem 1991;7974:7971-4.
122. Chiba H, Sawada N, Oyamada M, et al. Relationship between the expression of the gap junction protein and osteoblast phenotype in a human osteoblastic cell line during cell proliferation. Cell Struct Funct 1993;426:419-26.
123. Schiller PC, D'Ippolito G, Balkan W, Roos BA, Howard GA. Gap-junctional communication is required for the maturation process of osteoblastic cells in culture. Bone 2001;369:362-9.
124. Lecanda F, Warlow PM, Sheikh S, Furlan F, Steinberg TH, Civitelli R. Connexin43 deficiency causes delayed ossification, craniofacial abnormalitites, and osteoblast dysfunction. J Cell Biol 2000;943:931-43.
125. Van der Molen MA, Rubin CT, McLeod KJ, McCauley LK, Donahue HJ. Gap junctional intercellular communication contributes to hormonal responsiveness in osteoblastic networks. J Biol Chem 1996;12171:12165-71.
126. Civitelli R, Bacskai BJ, Mahaut SM, Adams SR, Avioli LV, Tsien RY. Single-cell analysis of cyclic AMP response to parathyroid hormone in osteoblastic cells. J Bone Miner Res 1994;1417:1407-17.
127. Lecanda F, Towler DA, Ziambaras K, et al. Gap junctional communication modulates gene expression in osteoblastic cells. Mol Biol Cell 1998;2258:2249-58.
128. Gramsch B, Gabriel HD, Wiemann M, et al. Enhancement of connexin 43 expression increases proliferation and differentiation of an osteoblast-like cell line. Exp Cell Res 2001;407:397-407.
129. Paznekas WA, Boyadjiev SA, Shapiro RE, et al. Connexin 43 (GJA1) Mutations Cause the Pleiotropic Phenotype of Oculodentodigital Dysplasia. Am J Hum Genet 2002;72.
130. Ilvesaro J, Vaananen K, Tuukkanen J. Bone-resorbing osteoclasts contain gap-junctional connexin-43. J Bone Miner Res 2000;926:919-26.
131. Furlan F, Lecanda F, Scheikh S, Weitzmann L, Civitelli R. Reduced osteogenic potential and support of osteoclastogenesis by connexin43-deficient osteoblasts. J Bone Miner Res 2000;15:S140.
132. Burnstock G, Dumsday B, Smythe A. Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol 1972;461:451-61.
133. 2Y subtypes. Drug Development Research 1994;219:206-19.
134. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998;492:413-92.
135. Jacobson KA, Jarvis MF, Williams M. Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 2002;4093:4057-93.
136. North RA, Surprenant A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 2000;580:563-80.
137. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002;1067:1013-67.
138. Buell G, Collo G, Rassendren F. P2X receptors: an emerging channel family. Eur J Neurosci 1996;2228:2221-8.
139. Collo G, North RA, Kawashima E, et al. Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 1996;2507:2495-2507.
140. 7). Science 1996;738:735-8.
141. Steinberg TH, Silverstein SC. Extracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line. J Biol Chem 1987;3122:3118-22.
142. Steinberg TH, Newman AS, Swanson JA, Silverstein SC. ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem 1987;8888:8884-8.
143. Chiozzi P, Murgia M, Falzoni S, Ferrari D, Di Virgilio F. Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures. Biochem Biophys Res Commun 1996;81X:176-81X.
144. Murgia M, Pizzo P, Steinberg TH, Di VF. Characterization of the cytotoxic effect of extracellular ATP in J774 mouse macrophages. Biochem J 1992;901:897-901.
145. Nijweide PJ, Modderman WE, Hagenaars CE. Extracellular adenosine triphosphate. A shock to hemopoietic cells. Clin Orthop 1995;92-102.
146. Zheng LM, Zychlinsky A, Liu CC, Ojcius DM, Young JD. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 1991;288:279-88.
147. Solini A, Chiozzi P, Morelli A, Fellin R, Di Virgilio F. Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci 1999;112(Pt 3):297-305.
148. Ferrari D, Chiozzi P, Falzoni S, et al. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 1997;1458:1451-8.
149. Chiozzi P, Sanz JM, Ferrari D, et al. Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor [published erratum appears in J Cell Biol 1997 Oct 20;139(2):following 571]. J Cell Biol 1997;706:697-706.
150. Falzoni S, Chiozzi P, Ferrari D, Buell G, Di Virgilio F. P2X7 receptor and polykarion formation. Mol Biol Cell 2000;3176:3169-76.
151. Dubyak GR, el MC. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993;265: C577-C606.
152. Barnard EA, Burnstock G, Webb TE. G protein-coupled receptors for ATP and other nucleotides: a new receptor family [see comments]. Trends Pharmacol Sci 1994;70:67-70.
153. Boarder MR, Weisman GA, Turner JT, Wilkinson GF. G protein-coupled P2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol Sci 1995;139:133-9.
154. Martin KA, Kertesy SB, Dubyak GR. Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol Pharmacol 1997;108:97-108.
155. Koshiba M, Apasov S, Sverdlov V, et al. Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc Natl Acad Sci USA 1997;836:831-6.
156. Dixon CJ, Bowler WB, Fleetwood P, Ginty AF, Gallagher JA, Carron JA. Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors. Br J Cancer 1997;39:34-9.
157. Kumagai H, Sacktor B, Filburn CR. Purinergic regulation of cytosolic calcium and phosphoinositide metabolism in rat osteoblast-like osteosarcoma cells. J Bone Miner Res 1991;708:697-708.
158. Reimer WJ, Dixon SJ. Extracellular nucleotides elevate [Ca2+]i in rat osteoblastic cells by interaction with two receptor subtypes. Am J Physiol 1992;263:C1040-C1048.
159. Schon C, Cuthbertson KS, Walsh CA, et al. Evidence for P2-purinoceptors on human osteoblast-like cells. J Bone Miner Res 1992;491:485-91.
160. Dixon CJ, Bowler WB, Walsh CA, Gallagher JA. Effects of extracellular nucleotides on single cells and populations of human osteoblasts: contribution of cell heterogeneity to relative potencies. Br J Pharmacol 1997;780:777-80.
161. Bowler WB, Birch MA, Gallagher JA, Bilbe G. Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblasts. J Bone Miner Res 1995;1145:1137-45.
162. Boyd RS, Duggan MJ, Shone CC, Foster KA. The effect of botulinum neurotoxins on the release of insulin from the insulinoma cell lines HIT-15 and RINm5F. J Biol Chem 1995;18218:18216-8.
163. Hoebertz A, Townsend-Nicholson A, Glass R, Burnstock G, Arnett TR. Expression of P2 receptors in bone and cultured bone cells. Bone 2000;510:503-10.
164. Nakamura E, Uezono Y, Narusawa K, et al. ATP activates DNA synthesis by acting on P2X receptors in human osteoblast-like MG-63 cells. Am J Physiol Cell Physiol 2000;279:C510-C519.
165. Gartland A, Hipskind RA, Gallagher JA, Bowler WB. Expression of a P2X7 receptor by a subpopulation of human osteoblasts. J Bone Miner Res 2001;856:846-56.
166. Modderman WE, Weidema AF, Vrijheid-Lammers T, Wassenaar AM, Nijweide PJ. Permeabilization of cells of hemopoietic origin by extracellular ATP4-: elimination of osteoclasts, macrophages, and their precursors from isolated bone cell populations and fetal bone rudiments. Calcif Tissue Int 1994;150:141-50.
167. Jones SJ, Gray C, Boyde A, Burnstock G. Purinergic transmitters inhibit bone formation by cultured osteoblasts. Bone 1997;399:393-9.
168. Hoebertz A, Mahendran S, Burnstock G, Arnett TR. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling. J Cell Biochem 2002;419:413-9.
169. Dixon SJ, Sims SM. P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development. Drug Development Research 2000;200:187-200.
170. Buckley KA, Wagstaff SC, McKay G, et al. Parathyroid hormone potentiates nucleotide-induced [Ca2+]i release in rat osteoblasts independently of Gq activation or cyclic monophosphate accumulation. A mechanism for localizing systemic responses in bone. J Biol Chem 2001;9571:9565-71.
171. Bowler WB, Dixon CJ, Halleux C, et al. Signaling in human osteoblasts by extracellular nucleotides. Their weak induction of the c-fos proto-oncogene via Ca2+ mobilization is strongly potentiated by a parathyroid hormone/cAMP- dependent protein kinase pathway independently of mitogen-activated protein kinase. J Biol Chem 1999;14324:14315-24.
172. Yu H, Ferrier J. ATP induces an intracellular calcium pulse in osteoclasts. Biochem Biophys Res Commun 1993;363:357-63.
173. Yu H, Ferrier J. Mechanisms of ATP-induced Ca2+ signaling in osteoclasts. Cell Signal 1994;914:905-14.
174. Weidema AF, Barbera J, Dixon SJ, Sims SM. Extracellular nucleotides activate non-selective cation and Ca(2+)-dependent K+ channels in rat osteoclasts. J Physiol (Lond) 1997;503(Pt 2):303-15.
175. Wiebe SH, Sims SM, Dixon SJ. Calcium signalling via multiple P2 purinoceptor subtypes in rat osteoclasts. Cell Physiol Biochem 1999;337:323-37.
176. Weidema AF, Dixon SJ, Sims SM. Activation of P2Y but not P2X(4) nucleotide receptors causes elevation of [Ca2+]i in mammalian osteoclasts. Am J Physiol Cell Physiol 2001;280:C1531-C1539.
177. Naemsch LN, Weidema AF, Sims SM, Underhill TM, Dixon SJ. P2X(4) purinoceptors mediate an ATP-activated, non-selective cation current in rabbit osteoclasts. J Cell Sci 1999;112(Pt23):4425-35.
178. Naemsch LN, Dixon SJ, Sims SM. Activity-dependent development of p2x7 current and ca2+ entry in rabbit osteoclasts. J Biol Chem 2001;39114:39107-14.
179. Buckley KA, Hipskind RA, Gartland A, Bowler WB, Gallagher JA. Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappaB ligand. Bone 2002;590:582-90.
180. Bowler WB, Littlewood EA, Bilbe G, Gallagher JA, Dixon CJ. P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption. Bone 1998;200:195-200.
181. Morrison MS, Turin L, King BF, Burnstock G, Arnett TR. ATP is a potent stimulator of the activation and formation of rodent osteoclasts. J Physiol (Lond) 1998;511(Pt 2):495-500.
182. Yu H, Ferrier J. Osteoclast ATP receptor activation leads to a transient decrease in intracellular pH. J Cell Sci 1995;108(Pt 9):3051-8.
183. Hoebertz A, Meghji S, Burnstock G, Arnett TR. Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y(1) receptor on bone cells. FASEB J 2001;1148:1139-48.
184. Steinberg TH, Jorgensen NR, Bong JS, et al. P2-mediated responses in osteoclasts and osteoclast-like cells. Drug Development Research 2000;49.
185. Cario T, Loirand G, Ferrier L, Pacaud P. Non-genomic inhibition of human P2X7 purinoceptor by I7beta-oestradiol. J Physiol 1998;508(Pt 3):659-66.
186. Gu BJ, Zhang W, Worthington RA, et al. A glu-496 to ala polymorphism leads to loss of function of the human p2x7 receptor. J Biol Chem 2001;11142:11135-42.
187. Wiley JS, Gu BJ, Zhang W, et al. Genetic polymorphisms of the human P2X7 receptor and relationship to function. Drug Development Research 2001;76:72-6.
188. Aonuma S, Kohama Y, Akai K, et al. Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem Pharm Bull (Tokyo) 1980;3339:3332-9.
189. Müller A, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S. Increase in gap junction conductance by an antiarrhythmic peptide. Eur J Pharmacol 1997;72:65-72.
190. Dhein S, Manicone N, Muller A, et al. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn Schmiedebergs Arch Pharmacol 1994;184:174-84.
191. Daleau P. Effects of antiarrhythmic agents on junctional resistance of guinea pig ventricular cell pairs. J Pharmacol Exp Ther 1998;1179:1174-9.